Multiple Sclerosis (MS) is a devastating demyelinating disease with a very high prevalence in North-East Scotland and in the Orkney and Shetland Islands. MS appears to be a multifactorial disorder with environmental and genetic elements and it has been proposed that these, in tandem, provoke an autoimmune response giving rise to the disease. Although there is no direct evidence of a specific virus being involved in MS, there are nevertheless grounds for suspecting a viral association. This review discusses these aspects of MS and suggests that a more aggressive approach to unravelling the role of viruses is needed.
MarieP. Sclerose en plaques et maladies infectieuses. Prog Med Paris1884; 12: 287–289.
2.
McFarlinDELachmannPJ. Hopeful genes and immunology. Nature1989; 341: 693–694.
3.
CookSDDowlingPC. Multiple sclerosis and viruses: An overview. Neurology1980; 30: 80–91.
4.
KurtzkeJF. Epidemiological contributions to multiple sclerosis: An overview. Neurology1980; 30: 61–79.
5.
EbersGCBulmanDESadovnickAD. A population based study of multiple sclerosis in twins. N Eng J Med1986; 315: 1638–1642.
6.
DeanGKurtzkeJF. On the risk of multiple sclerosis according to age at immigration to South Africa. Brit Med J1971; 3: 725–729.
7.
SadovnickADArmstrongHRiceGP. A population based study of multiple sclerosis in twins: Update. Ann Neurol1993; 33: 281–283.
8.
MumfordCJWoodNWKellar-WoodHThorpeJWMillerDHCompstonD.A.S., The British Isles survey of multiple sclerosis in twins. Neurology1994; 44: 11–15.
9.
EldridgeRHerndonCN. Multiple sclerosis in twins. N Eng J Med1987; 317: 50.
10.
HillertJ. Human leukocyte antigen studies in multiple sclerosis. Annal Neurol1994; 36: S15–S17.
11.
KurtzkeJF. Epidemiological evidence for multiple sclerosis as an infection. Clin Microbiol Rev1993; 6: 382–427.
12.
KurtzkeJFHyllestedK. Multiple sclerosis in the Faroe Islands: 1. Clinical and epidemiologicalfeatures. Ann Neurol1979; 5L6–21.
13.
CookSDDowlingPCRussellWC. Multiple sclerosis and canine distemper. Lancet1978; i: 605–606.
14.
PoserCMHibberdPLBenedikzJGudmundssonG. Analysis of the ‘epidemic’ of multiple sclerosis in the Faroe Islands. I. Clinical and epidemiological aspects. Neuroepidemiology1988; 7: 168–180.
15.
PoserCMHibberdPL. Analysis of the ‘epidemic’ of multiple sclerosis in the Faroe Islands. II Biostatistical aspects. Neuroepidemiology1988; 7: 181–189.
16.
CookeRG. Multiple sclerosis in the Faroe islands and the possible protective effect of early childhood exposure to the “MS agent”. Acta Neurol Scand1990; 82: 230–233.
17.
SheremataWAPoskanzerDCWithamDGMacLeodCLWhitesideME. Unusual occurence on a tropical island of multiple sclerosis. Lancet1985; ii: 618.
18.
DownieAWPhadkeJG. The Chief Medical Scientist Reports. Multiple sclerosis in North-East Scotland. Health Bulletin (Edinb)1984; 42/3: 151–156.
19.
DeanGGodallJDownieA. Prevalence of multiple sclerosis in the Outer Hebrides compared with North-East Scotland and the Orkney and Shetland islands. J Epidemiol Comm Health1981; 35: 110–113.
20.
FrancisDABatchelorJRMcDonaldWIHernJECDownieAW. Multiple sclerosis and HLA-DQwl. Lancet1986; i: 211.
21.
SwinglerRJKirkPFDarkeCCompstonDAS. HLA and multiple sclerosis in south-east Wales. J Neurol Neurosurg Psychiatry1987; 50: 1153–1155.
22.
WucherpfennigKWSetteASouthwoodS. Structural requirements for binding of an immunodominant myelin basic protein peptide to the DR2 isotypes and for its recognition by human T cell clones. J Exp Med1994; 179: 279–290.
23.
PoskanzerDCSeverJLSheridanJLPrenneyLB. Multiple sclerosis in the Orkney and Shetland Islands. IV: Viral antibody titres and viral infections. J Epidemiol Comm Health1980; 34: 258–264.
24.
PoskanzerDCSheridanJLPrenneyLBWalkerAM. Multiple sclerosis in the Orkney and Shetland Islands. II: The search for an exogenous aetiology. J Epidemiol Comm Health1980; 34: 240–252.
25.
SullivanCBVisscherBRDetelsR. Multiple sclerosis and age at exposure to childhood diseases and animals: Cases and their friends. Neurology1984; 34: 144–148.
26.
CompstonDASVakarelisBNPaulEMcDonaldWIBatchelorJRMimsCA. Viral infections in patients with multiple sclerosis and HLA-DR matched controls. Brain1986; 109: 325–344.
27.
EbersGC. Oligoclonal banding in multiple sclerosis. Ann NY Acad Sci1984; 436: 206–212.
28.
MehtaPDPatrickBAMehtaSPWisniewskiHM. Specificity of oligoclonal IgG bands against myelin proteins in chronic relapsing EAE in guinea pigs. J Immunol1987; 138: 746–751.
29.
BaigSOlssonOOlssonTLoveAJeanssonSLinkH. Cells producing antibodies to measles and herpes simplex virus in cerebrospinal fluid and blood of patients with multiple sclerosis and controls. Clin Exp Immunol1989; 78: 390–395.
30.
MattsonDHRoosRPArnasonBGW. Isoelectric focussing of the IgG eluted from multiple sclerosis and subacute sclerosing panencephalitis brains. Nature1980; 287: 335–337.
31.
VartdalFVandvikB. Multiple sclerosis: Electrofocussed “bands” of oligoclonal CSF IgG do not carry antibody activity against measles, varicella zoster or rotaviruses. J Neurol Sci1982; 54: 99–107.
SalmiAReunanenMIlonenJPaneliusM. Intrathecal antibody synthesis to virus antigens in multiple sclerosis. Clin Exp Immunol1983; 52: 241–249.
34.
JacobsonSRichertJRBiddisonWESatinskyAHartzmannRJMcFarlandHF. Measles virus-specific T4+ human cytotoxic T cell clones are restricted by class II HLA antigens. J Immunol1984; 133: 754–757.
35.
JacobsonSSekalyRPJacobsonCLMcFarlandHFLongEO. HLA class II restricted presentation of cytoplasmic measles virus antigens to cytotoxic T cells. J Virol1989; 63: 1756–1762.
36.
RichertJRRoseJWReuben-BurnsideC. Polypeptide specificities of measles virus-reactive T cell lines and clones derived from a patient with multiple sclerosis. J Immunol1986; 137: 2190–2194.
37.
LinkHSunJ-BWangZ et nl. Virus reactive and autoreactive T cells are accumulated in the cerebrospinal fluid of multiple sclerosis. J Neuroimmunol1992; 38: 63–74.
38.
OksenbergJRPanzaraMABegovichAB. Selection for T cell receptor Vß-Dß1ß rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. Nature1993; 362: 68–70.
39.
HaraHMoritaMIwakiT. Detection of Human T-Lymphotrophic Virus type 1 (HTLV-1) proviral DNA and analysis of the T cell receptor Vß CDR-3 sequences in spinal cord lesions of HTLV-1 associated myelopathy/tropical spastic paraparesis. J Exp Med1994; 180: 831–839.
40.
SteinmanLOksenbergJRBernardCCA. Association of susceptibility to multiple sclerosis with TCR genes. Immunol Today1992; 13: 49–51.
41.
BourdetteDNWhithamRHChouYK. Immunity to TCR peptides in multiple sclerosis. 1. Successful immunization of patients with synthetic Vß5.2 and Vß6.1 CDR2 peptide. J Immunol1994; 152: 2510–2519.
42.
HowellMDWintersSTOleeTPowellHCCarloDJBrostoffSW. Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides. Science1989; 246: 668–670.
43.
VandenbarkAAHashimGOffnerH. Immunization with synthetic T cell receptor V region peptide protects against EAE. Nature1989; 341: 541–544.
44.
ShimonkevitzRColburnCBurnhamJAMurrayRSKotzinBL. Clonal expansion of activated ? /d T cells in recent onset multiple sclerosis. Proc Natl Acad Sci (USA)1993; 90: 923–927.
45.
JohnsonRMLanckiDWSperlingAl. A murine CD4-, CD8- T cell receptor T?d lymphocyte clone specific for Herpes simplex virus glycoprotein I. J Immunol1992; 148: 983–988.
RaineCS. Multiple sclerosis: Immune system molecule expression in the central nervous system. J Neuropath Exp Neurol1994; 53: 328–337.
48.
PanitchHSHirschRLHaleyASJohnsonKP. Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet1987: i: 893–895
49.
SibleyWAEbersGCPanitchHSRederAT and the IFN-ß multiple sclerosis study group. Interferon-,ß lb is effective in relapsing-remitting multiple sclerosis. Neurology1993; 43: 655–661.
50.
PatyDWLiDKB. The interferon-ß multiple sclerosis study group. Interferon-beta lb is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multi-centre, randomised, double blind, placebo controlled trial. Neurology1993; 43: 662–667.
51.
NoronhaAToscasAJensenMA. Interferon beta augments suppressor cell function in multiple sclerosis. Ann Neurol1990; 27: 207–210
52.
RansohoffRMDevajyothiCEstesML. Interferon-beta specifically inhibits interferon induced class II major histocompatability complex gene transcription in a human astrocytoma cell line. J Neuroimmunol1991; 33: 103–112.
53.
NoronhaAToscasAJensenMA. Interferon beta decreases T cell activation and interferon gamma production in Multiple Sclerosis. J Neuroimmunol1993; 46: 145–154
54.
BrosnanCFSelmajKRaineCS. Hypothesis: A role for tumour necrosis factor in immune mediated demyelination and its relevance to multiple sclerosis. J Neuroimmunol1988; 18: 87–94.
55.
ShariefMKHentgesR. Association between tumour necrosis factor-a and disease progression in patients with multiple sclerosis lesions. N Eng J Med1991; 325: 467–472.
56.
SelmajKRaineCS. Tumour necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol1988; 23: 339–346.
57.
SelmajKRaineCSFarooqMNortonWTBrosnanCF. Cytokine cytotoxicity against oligodendrocytes: Apoptosis induced by lymphotoxin. J Immunol1991; 147: 1522–1529.
58.
HauserSLDoolittleTHLincolnRBrownRHDinarelloCA. Cytokine accumulations in the CSF of multiple sclerosis patients: Frequent detection of interleukin-1 and tumour necrosis factor but not interleukin-6. Neurology1990; 40: 1735–1739.
59.
SelmajKRaineCSCannellaBBrosnanCF. Identification of lymphotoxin and tumour necrosis factor in multiple sclerosis lesions. J Clin Invest1991; 87: 949–954.
60.
JohnsonRT. Viral aspects of multiple sclerosis. In handbook of Clinical Neurology. Eds: KoesterJCVinkenPJBruynGWKlawansHL. (Pub: Elsevier Sciences, Amsterdam) 1985; 47: 319–336.
61.
FieldEJCowshallSNarangHKBellTM, Viruses in multiple sclerosis?Lancet1972; ii: 280–281.
62.
ter MeulenVKoprowskiHIwasakiYKackellYMMullerD. Fusion of cultured multiple sclerosis brain cells with indicator cells: Presence of nucleocapsids and virions and isolation of parainfluenza type virus. Lancet1972; ii: 1–5.
63.
MitchellDNPorterfieldJSMitchelettiR. Isolation of an infectious agent from bone marrows of patients with multiple sclerosis. Lancet1978; ii: 387–391.
64.
NorrbyELinkHOlssonJE. Comparison of measles virus antibody titres in cerebrospinal fluids and sera from patients with multiple sclerosis and from controls. ArchNeurol1974; 30: 285–292.
65.
PrasadIBroomeJDPertschukLPGuptaJCookAW. Recovery of paramyxovirus from jejunum of patients with multiple sclerosis. Lancet1977; i: 117–119.
66.
WoyciechowskaJLMaddenDLSeverJL. Absence of measles-virus antigen in the jejunum of multiple sclerosis patients. Lancet1977; ii: 1046–1049.
67.
CosbySLMcQuaidSTaylorMJ. Examination of eight cases of multiple sclerosis and 56 neurological and non-neurological controls for genomic sequences of measles virus, canine distemper virus, imian virus 5 and rubella virus. J Gen Virol1989; 70: 2027–2036.
68.
GodecMSAsherDMMurrayRS. Absence of measles, mumps and rubella viral genomic sequences from multiple sclerosis brain tissue by poymerase chain reaction. Ann Neurol1992; 32: 401–404.
69.
ChanWWIC. Multiple sclerosis and dogs. Lancet1977; i: 487–488.
70.
ReadDNassimDSmithPPattersonCWarlowC. Multiple sclerosis and dog ownership. A case-control investigation. J Neurol Sci1982; 55: 359–367.
71.
SouberbielleBEMartin-MondiereCO'BrienMECardydakisCCesaroPDegosJD. A case controlled epidemiological study of MS in the Paris area with particular reference to past history and profession. Acta Neurol Scand1990; 82; 303–310.
72.
GoswamiKKAMorrisRJRastogiSCLangeLSRussellWC. A neutralising monoclonal antibody against a paramyxovirus reacts with a brain antigen. J Neuroimmunol1985; 9: 99–108.
73.
BrankinBWisdomGBAllenI.V.HawkinsSACosbySC. Antibodies to simian virus 5 in patients with multiple sclerosis and other neurological disorders. JNeurolSci1989; 89: 181–187.
74.
McLeanBNThompsonEJ. Antibodies against the paramyxovirus SV5 are not specific for cerebrospinal fluid from mutiple sclerosis patients. J Neurol Sci1989; 92: 261–266.
75.
VandvikBNorrbyE. Paramyxovirus SV5 and multiple sclerosis. Nature1989; 38: 769–771.
76.
GessainABarinFVernantJC. Antibodies to human T-lymphotropic virus type-1 in patients with tropical spastic parapereisis. Lancet1985; ii: 407–410.
77.
KoprowskiHDeFreitasECHarperM.E.. Multiple sclerosis and human T cell lymphotropic retroviruses. Nature;1985; 318: 154–160.
78.
OhtaMOhtaKMoriFNishitaniHSaidaT. Sera from patients with multiple sclerosis react with human T-cell lymphotropic virus-1 gag proteins but not env proteins — Western blotting analysis. J Immunol1986; 137: 3440–3443.
79.
ReddyEPSandberg-WollheimMMettusRVRayPEDeFreitasEKoprowskiH. Amplification and molecular cloning of HTLV-1 sequences from DNA of multiple sclerosis patients. Science1989; 243: 529–533.
80.
GreenbergSJErlichGDAbbotMAHurwitzBJWaldmannTAPoieszBJ, Detection of sequences homologous to human retroviral DNA in multiple sclerosis by gene amplification. Proc Natl Acad Sci (USA)1989; 86: 2878–2882.
81.
RasmussenHBKvinesdalBBClausenJ. Seroreactivity to human T cell leukaemia/lymphoma virus type-1 and related retroviruses in multiple sclerosis patients from Denmark and Faroes. Acta Neurol Scand1992; 86: 91–94
82.
PerronHGenyCLaurentA. Leptomingeal cell line from multiple sclerosis with reverse, transcriptase activity and viral particles. Res Virol1989; 140: 551–561.
83.
PerronHGenyCGenoulazOPellatJPerretJSeigneurinJM. Antibody to reverse transcriptase of human retroviruses in multiple sclerosis. Acta Neurol Scand1991; 84: 507–513.
84.
RasmussenHBPerronHClausenJ. Do endogenous retroviruses have an etiological implication in inflammatory and degenerative nervous system diseases. Acta Neurol Scand1993; 88: 190–198.
85.
BankiKMacedaJHurleyE. Human T-cell lymphotrophic virus (HTLV)related endogenous sequence HRES-1, encodes a 28 kDa protein. A possible autoantigen for HTLV-1 gag-reactive autoantibodies. Proc Natl Acad Sci. (USA)1992; 89: 1939–1943.
86.
KarpasAKampfUSidenAKochMPoserS. Lack of involvement of known human retroviruses in multiple sclerosis. Nature1986; 322: 177–178.
87.
ErlichGDGlaserJBBryz-GorniaV etal. Multiple sclerosis, retrovirus and PCR. The HTLV-MS working group. Neurology1991; 41: 335–343.
88.
MyhrKMFrostPGronningM. Abscence of HTLV-1 related sequences in MS from high prevalence areas in Western Norway. Acta Neurol Scand1994; 89: 65–68.
89.
HaahrSSommerlundMMoller-LarsenAMogensenSAndersenHM, Is multiple sclerosis caused by a dual infection with retrovirus and Epstein-Barr virus?Neuroepidemiology1992; 11: 299–303.
90.
SommerlundMPallesenGMoller-LarsenAHansenHJHaahrS. Retrovirus-like particles in an Epstein-Barr virus producing cell line derived from a patient with chronic progressive myelopathy. Acta Neurol Scand1993; 87: 71–76.
91.
WarnerHBCarpRI. Multiple sclerosis-An Epstein-Barr virus hypothesis. Medical Hypotheses1988; 25: 93–97.
PerronHSuhMLalandeB. Herpes simplex virus ICP0 and ICP4 immediate early proteins strongly enhance expression of a retrovirus harboured by a leptomingeal cell line from a patient with multiple sclerosis. J Gen Virol1993; 74: 65–67.
94.
BurksJSDevaldBLJankovskyLDGerdesJC. Two coronaviruses isolated from the central nervous system tissue of two multiple sclerosis patients. Science1980; 209: 933–934.
95.
MurrayRSBrownBBrainDCabiracGF. Detection of Coronavirus RNA and antigen in multiple sclerosis brain. Ann Neurol1992; 31: 525–533.
96.
MurrayRSCaiG-YHoelKZhangJ-YSoikeKFCabiracGF. Coronavirus infects and causes demyelination in primate central nervous system. Virology1992; 188: 274–284.
97.
SmallJAScangosGACorkLJayGKhouryG. The early region of human papovirus JC induces dysmyelination in transgenic mice. Cell1986; 46: 13–18.
98.
ShubinRAWeinerLP. Viruses and demyelination. In: Myelination and demyelination: Implications for multiple sclerosis (Ed. KimSU) pages 129–143. Pub: Plenum PressNY and London (1989).
99.
RosenthalAFujinamiRSLampertPW. Mechanism of Theiler's virus induced demyelination in nude mice. Lab Invest1986; 54: 515–522
100.
ClatchRJMelvoldRWMillerSDLiptonHL. Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease in mice is influenced by the H-2D region. Correlation with TMEV specific delayed-type hypersensitivity. J Immunol1985; 135: 1408–1414.
101.
FazakerleyJKWebbHE. Semliki forest virus induced immune demyelination: Adoptive transfer studies and viral persistence in nude mice. J Gen Virol1987; 68: 377–385.
102.
KermodeAGThompsonAJToftsP. Breakdown of the blood brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenic and clinical implication. Brain1990; 113: 1477–1489.
103.
SouberbielleBESwinglerRJDavidsonDLW. Western blotting analysis in patients with MS using human brain vessels as antigens. Acta Neurol Scand1992; 86: 397–402.
104.
NelsonJ. Frontiers in HIV pathogenesis: HIV in CNS. MRC AIDS Directed Programme Newsletter1993; 17: 16–17.
105.
PoserCM. Pathogenesis of multiple sclerosis: A critical reappraisal. Acta Neuropath (Berlin)1986; 71: 1–10.
106.
OlssonTDienerPLjungdahlAHojebergBvan der MeidePMKristenssonK. Facial nerve transection causes expansion of myelin autoreactive T cells in regional lymph nodes and T cell homing to the facial nucleus. Autoimmunity1992; 13: 117–126.
107.
MassaPTDorriesRter MeulenV. Viral particles induce la antigen expression on astrocytes. Nature1986; 320: 543–546.
108.
WaksmanB. Human disease: Mechanisms in multiple sclerosis. Nature1985; 318: 104–105.
109.
DalgleishAGFazakerleyJKWebbHE. Do human T-lymphotropic viruses (HTLVs) and other enveloped viruses induce autoimmunity in multiple sclerosis?. Neuropath Appl Neurobiol1987; 13: 241–250.
110.
McCarronRMRakeMSpatzMMcFarlinDE. Cerebral vascular endothelial cells are effective targets for in vitro lysis by encephaltogenic T lymphocytes. J Immunol1991; 147: 503–508.
111.
HayashiTMorimotoCBurksJSKerrCHauserSL. Dual-label immunocytochemistry of active multiple sclerosis lesions: Major histocompatability complex and activation antigens. Ann Neurol.1988; 24: 523–531.
112.
WebbHEFazakerleyJK. Can viral envelope glycolipids produce autoimmunity with reference to the CNS and multiple sclerosis?Neuropath Appl Neurobiol1984; 10: 1–10.
113.
FujinamiRSOldstoneMBWroblewskaZFrankelMEKoprowskiH. Molecular mimicry in virus infection. Cross reaction of measles virus phosphoprotein of Herpes simplex virus protein with human intermediate filaments. Proc Natl Acad Sci (USA)1983; 80: 2346–2350.
114.
FujinamiRSOldstoneM.B.. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: Mechanism for autoimmunity. Science1985; 223: 1043–1045.
115.
YamadaMZurbriggenAFujinamiRS. Monoclonal antibody to Theiler's murine encephalomyelitis virus defines a determinant on myelin and oligodendrocytes and augments demyelination in experimental allergic encephalomyelitis. J Exp Med1990; 171: 1893–1907.
BrayPFLikaJBrayPFCulpKWSchlightJP. Antibodies to Epstein-Barr nuclear antigen (EBNA) in multiple sclerosis CSF and two pentapeptide sequence identities between EBNA and myelin basic protein. Neurology1992; 42: 1798–1804.
118.
JahnkeUFischerEHAlvordEC. Sequence homology between certain viral proteins and proteins related to encephalomyelitis and neuritis. Science1985; 229: 282–284.
119.
ShawSYLaursenRALeesMB. Analogous amino acid sequences in myelin proteolipid and viral proteins. FEBS lett1986; 207: 260–270.
120.
OtaKMatsuiMMilfordELMackinGAWeinerHLHaflerDA. T cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature1990; 346: 183–187.
121.
DaviesJMSonodaSYashikiSOsameMCarnegiePR. Mimicry between HTLV-1 and myelin basic protein: No response in HTLV-1 associated myelopathy patients. J Neuroimmunol1992; 41: 239–244.
122.
HaflerDAWeinerHL. MS: A CNS and systemic autoimmune disease. Immunol. Today1991; 10: 104–107.
SibleyWABamfordCRClarkK, Clinical viral infections in multiple sclerosis. Lancet1985; i: 1313–1315.
125.
GovermanJWoodsALarsonLWeinerLPHoodLZallerDM. Transgenic mice that express a myelin basic protein specific T-cell receptor develop spontaneous autoimmunity. Cell1993; 72: 551–560.
